{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:13:33Z","timestamp":1759482813785},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.transproceed.2006.08.104","type":"journal-article","created":{"date-parts":[[2006,11,16]],"date-time":"2006-11-16T19:15:55Z","timestamp":1163704555000},"page":"2807-2812","source":"Crossref","is-referenced-by-count":4,"title":["Additional Effect of Hyperparathyroidism on Inflammatory Status and rHuEPO Requirements in Hemodialysis Patients"],"prefix":"10.1016","volume":"38","author":[{"given":"E.","family":"Tutal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Arat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.N.","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Haberal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2006.08.104_bib1","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM199810083391507","article-title":"Care of patients undergoing hemodialysis","volume":"339","author":"Ifudu","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2006.08.104_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ki.1989.18","article-title":"The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin","volume":"35","author":"Eschbach","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.08.104_bib3","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/ndt\/13.6.1384","article-title":"Primary and secondary uraemic hyperpareathyroidism: from initial clinical observations to recent findings","volume":"13","author":"Dr\u00fceke","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.104_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ki.1992.302","article-title":"A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects","volume":"42","author":"Eschbach","year":"1992","journal-title":"Kidney Int"},{"issue":"4 Suppl 3","key":"10.1016\/j.transproceed.2006.08.104_bib5","first-page":"S192","article-title":"NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure","volume":"30","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2006.08.104_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000013563","article-title":"Hyperparathyroidism and anemia in renal failure","volume":"20","author":"Gallieni","year":"2000","journal-title":"Am J Nephrol"},{"issue":"Suppl 5","key":"10.1016\/j.transproceed.2006.08.104_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ndt\/17.suppl_5.38","article-title":"Patient characteristics determining rHuEPO dose requirements","volume":"17","author":"Ifudu","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 7","key":"10.1016\/j.transproceed.2006.08.104_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/16.suppl_7.25","article-title":"Hyporesponsiveness to recombinant human erythropoietin","volume":"16","author":"Dr\u00fceke","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.104_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.1989.43","article-title":"Iron status in patients receiving erythropoietin for dialysis-associated anemia","volume":"35","author":"Van Wyck","year":"1989","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2006.08.104_bib10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archinte.1976.03630080029010","article-title":"Primary hyperparathyroidism and anemia","volume":"136","author":"Fako","year":"1976","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transproceed.2006.08.104_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/archinte.1977.03630170020008","article-title":"Anemia in primary hyperparathyroidism","volume":"137","author":"Boxer","year":"1977","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transproceed.2006.08.104_bib12","series-title":"Prescribing hemodialysis: a guide to urea modeling","first-page":"65","author":"Depner","year":"1991"},{"issue":"Suppl 5","key":"10.1016\/j.transproceed.2006.08.104_bib13","first-page":"S1","article-title":"European best practice guidelines for the management of anaemia in patients with chronic renal failure","volume":"14","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.104_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0272-6386(97)90339-5","article-title":"High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients","volume":"29","author":"Barany","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 4","key":"10.1016\/j.transproceed.2006.08.104_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ndt\/15.suppl_4.43","article-title":"European best practice guidelines 14\u201316: inadequate response to epoetin","volume":"15","author":"Horl","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.104_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.transproceed.2003.11.022","article-title":"Clinical consequences of intermittent elevation of C-reactive protein levels in hemodialysis patients","volume":"36","author":"Sezer","year":"2004","journal-title":"Transplant Proc"},{"issue":"Suppl 6","key":"10.1016\/j.transproceed.2006.08.104_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ndt\/10.supp6.27","article-title":"Cellular mechanism of resistance to erythropoietin","volume":"10","author":"Casadevall","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.104_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.semnephrol.2004.06.009","article-title":"Inflammation: cause of vascular disease and malnutrition in dialysis patients","volume":"24","author":"Kayse","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.transproceed.2006.08.104_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00002480-200101000-00017","article-title":"Predictors of erythropoietin responsiveness in chronic hemodialysis patients","volume":"47","author":"Tonelli","year":"2001","journal-title":"ASAIO J"},{"issue":"Suppl 2","key":"10.1016\/j.transproceed.2006.08.104_bib20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ndt\/10.supp2.62","article-title":"R-HuEPO hyporesponsiveness\u2014who and why?","volume":"10","author":"Drueke","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2006.08.104_bib21","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/0006-291X(89)90851-6","article-title":"Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis","volume":"162","author":"Lowik","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.transproceed.2006.08.104_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0006-291X(91)91360-O","article-title":"Effect of parathyroid hormone on release of interleukin 1 and interleukin 6 from cultured mouse osteoblastic cells","volume":"179","author":"Li","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.transproceed.2006.08.104_bib23","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI118157","article-title":"Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption","volume":"96","author":"Greenfield","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transproceed.2006.08.104_bib24","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1210\/jc.81.10.3450","article-title":"Circulating levels of interleukin-6 and tumor necrosis factor-a are elevated in primary hyperparathyroidism and correlate with markers of bone resorption\u2014a clinical research center study","volume":"81","author":"Grey","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2006.08.104_bib25","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.mehy.2004.03.041","article-title":"Secondary hyperparathyroidism promotes the acute phase response - a rationale for supplemental vitamin D in prevention of vascular events in the elderly","volume":"64","author":"McCarty","year":"2005","journal-title":"Medical Hypotheses"},{"key":"10.1016\/j.transproceed.2006.08.104_bib26","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1210\/jc.2003-030358","article-title":"Bone turnover in prolonged critical illness: effect of vitamin D","volume":"88","author":"Van den Berghe","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.transproceed.2006.08.104_bib27","first-page":"420","article-title":"Secondary hyperparathyroidism as cause of resistance to treatment with erythropoietin: effect of parathyroidectomy","volume":"45","author":"Goicoechea","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transproceed.2006.08.104_bib28","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ndt\/12.3.514","article-title":"High-dose alfacalcidol improves anaemia in patients on haemodialysis","volume":"12","author":"Albitar","year":"1997","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113450601044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004113450601044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T12:50:27Z","timestamp":1547211027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004113450601044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S004113450601044X"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2006.08.104","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}